Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells.

Azithromycin may antagonize inhaled tobramycin when targeting Pseudomonas aeruginosa in cystic fibrosis. Ann Am Thorac Soc (2014) 1.43

Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PLoS One (2009) 1.26

Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother (2007) 1.05

Suppressive effects of azithromycin on zymosan-induced production of proinflammatory mediators by human corneal epithelial cells. Invest Ophthalmol Vis Sci (2010) 0.98

Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice. Inflamm Res (2009) 0.96

State of progress in treating cystic fibrosis respiratory disease. BMC Med (2012) 0.96

Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics. Mediators Inflamm (2012) 0.95

Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa. Chest (2012) 0.95

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis. Infect Drug Resist (2011) 0.90

Effect of gingivitis on azithromycin concentrations in gingival crevicular fluid. J Periodontol (2012) 0.88

Macrolide antibiotics like azithromycin increase lipopolysaccharide-induced IL-8 production by human gingival fibroblasts. Eur J Med Res (2009) 0.88

Azithromycin concentrations in blood and gingival crevicular fluid after systemic administration. J Periodontol (2011) 0.86

The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice. Immunology (2015) 0.80

Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis. Antimicrob Agents Chemother (2014) 0.80

Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis. Inflammopharmacology (2013) 0.79

Adult onset lung disease following transient disruption of fetal stretch-induced differentiation. Respir Res (2009) 0.78

MicroRNA Expression in Cystic Fibrosis Airway Epithelium. Biomolecules (2013) 0.75

Cystic fibrosis - a multiorgan protein misfolding disease. Future Sci OA (2015) 0.75

Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation. Respir Res (2017) 0.75

Association between carrier screening and incidence of cystic fibrosis. JAMA (2009) 1.78

IL-4 is a potent modulator of ion transport in the human bronchial epithelium in vitro. J Immunol (2002) 1.18

Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells. J Virol (2006) 1.09

Glutathione inhalation treatments in cystic fibrosis: the interference of airway γ-glutamyltransferase. Am J Respir Crit Care Med (2014) 1.08

Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother (2007) 1.05

IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer. Vaccine (2010) 1.02

Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. PLoS One (2011) 0.98

MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells. Am J Respir Cell Mol Biol (2006) 0.93

Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells. Am J Respir Cell Mol Biol (2008) 0.93

MAP kinases and NF-kappaB collaborate to induce ICAM-1 gene expression in the early phase of adenovirus infection. Virology (2003) 0.93

Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers. Am J Med Genet A (2005) 0.93

Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Sp1 superfamily. Biochem Biophys Res Commun (2007) 0.92

Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function. Am J Physiol Lung Cell Mol Physiol (2010) 0.88

Modulators of sphingolipid metabolism reduce lung inflammation. Am J Respir Cell Mol Biol (2011) 0.87

Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expression. BMC Struct Biol (2008) 0.87

Effects of decoy molecules targeting NF-kappaB transcription factors in Cystic fibrosis IB3-1 cells: recruitment of NF-kappaB to the IL-8 gene promoter and transcription of the IL-8 gene. Artif DNA PNA XNA (2012) 0.87

Anti-inflammatory effect of miglustat in bronchial epithelial cells. J Cyst Fibros (2008) 0.85

Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients. Eur J Hum Genet (2003) 0.85

Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. Biochem Pharmacol (2010) 0.85

Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial. J Aerosol Med Pulm Drug Deliv (2013) 0.83

Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum. PLoS One (2012) 0.83

TG15 T5 allele in clinically discordant monozygotic twins with cystic fibrosis. Am J Med Genet A (2007) 0.82

Phospholipase C-β3 is a key modulator of IL-8 expression in cystic fibrosis bronchial epithelial cells. J Immunol (2011) 0.82

MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects. Integr Biol (Camb) (2012) 0.82

Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells. Am J Respir Cell Mol Biol (2008) 0.81

A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients. Clin Chem Lab Med (2010) 0.80

Absence of a gender gap in survival. An analysis of the Italian registry for cystic fibrosis in the paediatric age. J Cyst Fibros (2011) 0.79

Late generation lentiviral vectors: evaluation of inflammatory potential in human airway epithelial cells. Virus Res (2009) 0.79

Editorial: The role of macrophages and their scavenger receptors in cystic fibrosis. J Leukoc Biol (2009) 0.79

CFTR mutation in an Arab patient: clinical and functional features of 875+1G-->A/875+1G-->A genotype. J Cyst Fibros (2009) 0.78

Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors. Biomark Insights (2007) 0.78

Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. J Cyst Fibros (2011) 0.78

Cationic trypsinogen and pancreatic secretory trypsin inhibitor gene mutations in neonatal hypertrypsinaemia. Eur J Hum Genet (2003) 0.77

Detection of CFTR protein in human leukocytes by flow cytometry. Cytometry A (2014) 0.77

Further characterization of Shwachman-Diamond syndrome: psychological functioning and quality of life in adult and young patients. Am J Med Genet A (2012) 0.76

Chemical conjugation of DeltaF508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions. Am J Physiol Lung Cell Mol Physiol (2008) 0.76

Incidence of Shwachman-Diamond syndrome. Pediatr Blood Cancer (2012) 0.76

Virtual screening against p50 NF-kappaB transcription factor for the identification of inhibitors of the NF-kappaB-DNA interaction and expression of NF-kappaB upregulated genes. ChemMedChem (2009) 0.76

Virtual screening against nuclear factor κB (NF-κB) of a focus library: Identification of bioactive furocoumarin derivatives inhibiting NF-κB dependent biological functions involved in cystic fibrosis. Bioorg Med Chem (2010) 0.76

Challenging the diagnosis of cystic fibrosis in a patient carrying the 186-8T/C allelic variant in the CF transmembrane conductance regulator gene. BMC Pulm Med (2014) 0.75

The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic: a functional characterization of its relevance for cystic fibrosis. BMC Med Genet (2006) 0.75

γ-Glutamyltransferase catabolism of S-nitrosoglutathione modulates IL-8 expression in cystic fibrosis bronchial epithelial cells. Free Radic Biol Med (2013) 0.75

Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease. J Cyst Fibros (2010) 0.75

Impaired CFTR function in mild cystic fibrosis associated with the S977F/T5TG12complex allele in trans with F508del mutation. J Cyst Fibros (2013) 0.75

Influence of perfusate temperature on nasal potential difference. Eur Respir J (2012) 0.75

Absence of acquired copy number neutral loss of heterozygosity (CN-LOH) of chromosome 7 in a series of 10 patients with Shwachman-Diamond syndrome. Br J Haematol (2014) 0.75

An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. Am J Med Genet A (2011) 0.75